Keith Meister, Corvex Management's chief investment officer, will join Illumina's board starting March 28. He's no stranger ...

Health care companies slid as traders retreated from high-risk issues. Shares of obesity-drug maker Novo Nordisk and Hims & Hers Health, the compounding pharmacy seeking to compete with the ...

Activist investor Keith Meister will join the board of gene-sequencing maker Illumina , and current board member Scott ...

McCormick reports first-quarter financial results that underwhelm Wall Street. The energy giant said it is targeting hydrocarbon production growth and plans to increase shareholder distributions to 40 ...

At the same time, Keith Meister, managing partner and chief investment officer of the hedge fund Corvex Management, will take ...

Illumina on Tuesday added activist investor Keith Meister to its board and named director Scott Gottlieb, a former FDA ...

Illumina (ILMN) has had an “eventful” 24 hours, featuring the announcements that the IR and Chief Information Officer are departing, while ...

JPMorgan partners with Affirm, FBI investigates Tesla attacks, Waymo expands to D.C., and Plenty files for bankruptcy in this morning's Bay Area news roundup. Also, The San Francisco condo market is ...

Struggling gene-sequencing machine and chemical company Illumina (ILMN) has fallen further into the hands of activist investors. Keith ...

Keith Meister’s hedge fund Corvex Management has a 2.5% stake in the gene-sequencing machine maker.

Illumina Inc. added activist investor Keith Meister to its board and elevated director Scott Gottlieb, a former head of the US Food and Drug Administration, to chair as the gene sequencing giant ...

McCormick reports first-quarter financial results that underwhelm Wall Street. The energy giant said it is targeting hydrocarbon production growth and plans to increase shareholder distributions to 40 ...